CHARLES SCHWAB INVESTMENT MANAGEMENT INC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$886,771
-7.7%
291,701
-0.1%
0.00%
Q2 2023$960,858
+29.5%
292,054
+25.2%
0.00%
Q1 2023$741,830
-51.8%
233,280
+4.9%
0.00%
Q4 2022$1,538,364
+21.4%
222,307
+11.1%
0.00%
Q3 2022$1,267,000
+61.0%
200,143
+5.3%
0.00%
Q2 2022$787,000
-10.9%
190,048
+4.5%
0.00%
Q1 2022$883,000
-50.1%
181,935
+2.8%
0.00%
-100.0%
Q4 2021$1,769,000
-45.5%
177,033
+4.3%
0.00%0.0%
Q3 2021$3,245,000
-77.5%
169,759
-62.4%
0.00%
-80.0%
Q2 2021$14,445,000
+55.4%
451,679
+46.5%
0.01%
+66.7%
Q1 2021$9,298,000
-34.4%
308,385
-5.8%
0.00%
-50.0%
Q4 2020$14,173,000
-18.6%
327,527
+1.5%
0.01%
-25.0%
Q3 2020$17,416,000
-8.8%
322,803
+3.2%
0.01%
-11.1%
Q2 2020$19,097,000
+58.3%
312,851
+19.2%
0.01%
+28.6%
Q1 2020$12,063,000
-46.8%
262,450
+1.6%
0.01%
-41.7%
Q4 2019$22,672,000
-3.0%
258,362
+1.5%
0.01%
-14.3%
Q3 2019$23,379,000
-23.9%
254,611
+5.4%
0.01%
-26.3%
Q2 2019$30,730,000
-16.5%
241,584
+3.3%
0.02%
-20.8%
Q1 2019$36,812,000
+71.2%
233,978
+7.9%
0.02%
+50.0%
Q4 2018$21,503,000
-28.6%
216,758
+5.1%
0.02%
-20.0%
Q3 2018$30,097,000
-27.2%
206,142
-21.8%
0.02%
-33.3%
Q2 2018$41,351,000
-27.2%
263,463
-20.8%
0.03%
-31.8%
Q1 2018$56,781,000
+7.7%
332,536
+12.3%
0.04%
+4.8%
Q4 2017$52,731,000
+44.0%
296,073
+11.0%
0.04%
+31.2%
Q3 2017$36,631,000
+98.6%
266,693
+51.9%
0.03%
+88.2%
Q2 2017$18,440,000
+19.4%
175,532
+3.4%
0.02%
+13.3%
Q1 2017$15,439,000
+61.9%
169,839
+9.9%
0.02%
+50.0%
Q4 2016$9,539,000
+0.2%
154,599
+10.0%
0.01%
-9.1%
Q3 2016$9,523,000
+51.1%
140,491
-3.5%
0.01%
+37.5%
Q2 2016$6,302,000
+46.0%
145,569
+43.4%
0.01%
+33.3%
Q1 2016$4,315,000
-27.6%
101,521
+9.4%
0.01%
-25.0%
Q4 2015$5,961,000
-20.7%
92,818
+5.7%
0.01%
-27.3%
Q3 2015$7,516,000
-3.5%
87,851
+89.9%
0.01%0.0%
Q2 2015$7,789,000
-19.8%
46,259
-42.5%
0.01%
-21.4%
Q1 2015$9,716,000
+86.8%
80,447
+41.9%
0.01%
+75.0%
Q4 2014$5,200,000
+201.6%
56,693
+18.0%
0.01%
+166.7%
Q3 2014$1,724,000
+34.8%
48,048
+45.0%
0.00%
+50.0%
Q2 2014$1,279,000
+272.9%
33,146
+120.4%
0.00%
+100.0%
Q1 2014$343,000
+11.0%
15,042
+2.5%
0.00%0.0%
Q4 2013$309,000
-20.2%
14,682
+3.0%
0.00%0.0%
Q3 2013$387,00014,2500.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders